Ondansetron
NDC 71335-1314, Ondansetron, tablet, orally disintegrating, from Bryant Ranch Prepack.
- Product NDC
- 71335-1314
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090469
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1314 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONDANSETRON4 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71335-1314-0 | 71335131400 | 90 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-0) |
| 71335-1314-1 | 71335131401 | 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-1) |
| 71335-1314-2 | 71335131402 | 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-2) |
| 71335-1314-3 | 71335131403 | 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-3) |
| 71335-1314-4 | 71335131404 | 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-4) |
| 71335-1314-5 | 71335131405 | 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-5) |
| 71335-1314-6 | 71335131406 | 9 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-6) |
| 71335-1314-7 | 71335131407 | 5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-7) |
| 71335-1314-8 | 71335131408 | 15 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-8) |
| 71335-1314-9 | 71335131409 | 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ee668456-a214-4452-ab9d-ec00eaa41d79
Use it
Look up 71335-1314 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1314 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71335-1314. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.